Journal of the American Academy of Child & Adolescent Psychiatry. 45:1440-1455
ISSN:
0890-8567
DOI:
10.1097/01.chi.0000240840.63737.1d
Popis:
Objective To compare the rates of physical, psychiatric, and suicide-related events in adolescents with MDD treated with fluoxetine alone (FLX), cognitive-behavioral therapy (CBT), combination treatment (COMB), or placebo (PBO).